http://INFO.SIBIAMEDICALCENTRE.COM
http://INFO.SIBIAMEDICALCENTRE.COM

Checking delivery availability...

background-sm
Search
3

Updates found with 'device utilizing rotational field quantum magnetic resonance'

Page  1 1

Updates found with 'device utilizing rotational field quantum magnetic resonance'

World Arthritis Day 2017Cytotron the alternative to Knee surgery in Sibia Medical Centre, Ludhiana, Punjab (India)drsibia@gmail.com , #+919814034818Oct. 12 2017 Ludhiana (India): Millions of people throughout the world are affected by arthritis and World Arthritis Day was brought about by the Arthritis Foundation to raise awareness of this condition and how it affects the lives of those that suffer with it. To spread awareness Sibia Medical Centre observed World Arthritis day and gave information about Cytotron, the treatment millions of patients world over have been waiting for to relieve them of pain of arthritis. This new revolutionary device available at Sibia Medical Centre is developed after nine years of research to cure osteoarthritis by regenerating new cartilage without surgery or injections. Osteoarthritis is a degenerative disease, more in females and gradually worsens with age causing pain, stiffness, grating sensation, loss of mobility and forcing many to use walking stick, walker or wheel-chair and some even get bedridden. Osteoarthritis is also commoner in sport persons.Cytotron produces Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR) by 288 guns controlled by high-tech computers to stimulate cartilage regeneration. Most patients treated had lost all hope and were advised knee replacement. After treatment most have pain relief and few require pain killers and can walk, climb stairs and lead an improved quality of life. Results vary according to the disease process and many could do away with their walking sticks or wheel chairs and no longer require knee replacement. These patients are also saved from the harmful effects of the pain killer medicines on the liver and kidneys. Cytotron can treat osteoarthritis of the hip, knee, ankle, shoulder, elbow, wrist joints and also of the back. Dr Sibia said that even with such advanced technology the role of exercise, working to reduce weight and assist devices should not be ignored to maintain long-term relief.Cytotron is treatment of the future and is available in Sibia Medical centre, Ludhiana (Punjab) in North India. Cytotron has been written about in: Indian Journal of Aerospace Medicine, Sainik Samachar (Journal of India's Armed Forces), Current Science, The Week, Red Hering, Business World, Newsweek, Times of India, Hindustan Times, Deccan HeraldRevolutionaryHundreds saved from costly and risky knee surgery.Breakthrough: Cartilage re-growth made possible for the first time enabling more comfortable walk without pain killers.Method: Rays focused ½ to 1 hour daily for 21 days.Safe & Comfortable: No pain or side effects.Whom is Cytotron for? Advanced osteoarthritis.Early osteoarthritis – to reverse arthritis and avoid crippling end stage. Helpful in Rheumatoid arthritis also.Proven results: MRI and X-ray documented.Dr. S. S. Sibia, Director, Sibia Medical Centre, B XIX – 568 A, Civil Lines, Ludhiana, Punjab, IndiaMb: +91-98140-34818, E-mail: drsibia@gmail.com.Web: www.sibiamedicalcentre.comKey words: World Arthritis Day 2017, Cytotron, alternative to Knee surgery, arthritis, World Arthritis Day, Arthritis Foundation, osteoarthritis, regenerating new cartilage, without surgery, injections, degenerative disease, pain, stiffness, grating sensation, loss of mobility, walking stick, walker, Rotational Field Quantum Nuclear Magnetic Resonance, RFQMR, knee replacement, pain relief, pain killers, walk, climb stairs, quality of life, wheelchair, knee replacement, harmful effects of pain killer medicines, liver, kidney, hip, knee, ankle, shoulder, elbow, wrist joints, back, reduce weight, treatment of the future and is available in Sibia Medical centre, Ludhiana (Punjab) in North India, Indian Journal of Aerospace Medicine, Sainik Samachar, Journal of India's Armed Forces, Current Science, The Week, Red Hering, Business World, Newsweek, Times of India, Hindustan Times, Deccan Herald, knee surgery, Cartilage re-growth, comfortable walk, without pain killers, Advanced osteoarthritis, Early osteoarthritis, reverse arthritis, Rheumatoid arthritis, MRI, X-ray, tissue engineering, Arthritis pain, regenerate, repair joint cartilage, fight Cancer, tumor cell growth, Dr. S. S. Sibia, Sibia Medical Centre, Ludhiana, Punjab, India, Mb: +91-98140-34818, E-mail: drsibia@gmail.com.Web: www.sibiamedicalcentre.com, Dr. S. S. Sibia, www.sibiamedicalcentre.com
Send Enquiry
Read More
World Arthritis Day 2017Cytotron the alternative to Knee surgery in Sibia Medical Centre, Ludhiana, Punjab (India)drsibia@gmail.com #+919814034818Oct. 12 2017 Ludhiana (India): Millions of people throughout the world are affected by arthritis and World Arthritis Day was brought about by the Arthritis Foundation to raise awareness of this condition and how it affects the lives of those that suffer with it. To spread awareness Sibia Medical Centre observed World Arthritis day and gave information about Cytotron, the treatment millions of patients world over have been waiting for to relieve them of pain of arthritis. This new revolutionary device available at Sibia Medical Centre is developed after nine years of research to cure osteoarthritis by regenerating new cartilage without surgery or injections. Osteoarthritis is a degenerative disease, more in females and gradually worsens with age causing pain, stiffness, grating sensation, loss of mobility and forcing many to use walking stick, walker or wheel-chair and some even get bedridden. Osteoarthritis is also commoner in sport persons.Cytotron produces Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR) by 288 guns controlled by high-tech computers to stimulate cartilage regeneration. Most patients treated had lost all hope and were advised knee replacement. After treatment most have pain relief and few require pain killers and can walk, climb stairs and lead an improved quality of life. Results vary according to the disease process and many could do away with their walking sticks or wheel chairs and no longer require knee replacement. These patients are also saved from the harmful effects of the pain killer medicines on the liver and kidneys. Cytotron can treat osteoarthritis of the hip, knee, ankle, shoulder, elbow, wrist joints and also of the back. Dr Sibia said that even with such advanced technology the role of exercise, working to reduce weight and assist devices should not be ignored to maintain long-term relief.Cytotron is treatment of the future and is available in Sibia Medical centre, Ludhiana (Punjab) in North India. Cytotron has been written about in: Indian Journal of Aerospace Medicine, Sainik Samachar (Journal of India's Armed Forces), Current Science, The Week, Red Hering, Business World, Newsweek, Times of India, Hindustan Times, Deccan HeraldRevolutionaryHundreds saved from costly and risky knee surgery.Breakthrough: Cartilage re-growth made possible for the first time enabling more comfortable walk without pain killers.Method: Rays focused ½ to 1 hour daily for 21 days.Safe & Comfortable: No pain or side effects.Whom is Cytotron for? Advanced osteoarthritis.Early osteoarthritis – to reverse arthritis and avoid crippling end stage. Helpful in Rheumatoid arthritis also.Proven results: MRI and X-ray documented.Dr. S. S. Sibia, Director, Sibia Medical Centre, B XIX – 568 A, Civil Lines, Ludhiana, Punjab, IndiaMb: +91-98140-34818, E-mail: drsibia@gmail.com.Web: www.sibiamedicalcentre.com
Send Enquiry
Read More
Sibia Medical Centre celebrates 15 Years as leading External Counter Pulsation Therapy (ECP / EECP) authority in IndiaSibia Medical Centre developed a lifestyle program and manages four ECP / EECP devices along with Chelation therapy to create heart bypass naturally.Ludhiana, Punjab (India): SIbia Medical Centre announced today that it has marked 15 years in the field of External Counter Pulsation (also known as Enhanced External Counter Pulsation, ECP and EECP). Dr Sibia, Director of the centre is one the world’s leading authorities on its practice, efficacy and effect on cardiovascular disease and a variety of other illnesses. His heart rehabilitation program is a disease- prevention and lifestyle-modification program. For over a decade and a half Dr Sibia has been a pioneer utilizing ECP, the FDA-cleared, non-surgical and medication-free therapy, to assist those suffering from end-stage cardiovascular disease. At the same time, he has seen the positive effects of ECP therapy combined with lifestyle modification and disease prevention program. SIbia Medical Centre manages four ECP machines that deliver ECP therapy using methodology and protocols multiple diseases. Dr Sibia has devoted attention to the mechanics of ECP on multiple diseases and not just angina pectoris, chest pain, atherosclerosis and end-stage cardiovascular disease. Dr Sibia informed that ECP could have a role in prevention and reversal of a variety of other circulatory and inflammatory diseases such as anti-aging, testosterone improvement erectile dysfunction, hypertension, stroke, diabetes, for renal failure in addition to using ECP for sports enhancement and injury.Dr Sibia educates clients to seize control of their lifestyle with vegan nutrition, exercise and stress reduction. Dr Sibia Therapy believes that cardiovascular disease can be prevented by modification of risk factors as well as elimination of animal byproducts from the diet. Dr Sibia said the high rate of cardiac deaths can be brought down with proper life style and preventive ECP therapy sessions especially for those at high risk such as diabetics, hypertensives, smokers and high stress executives. ECP should be a serious thought for the corporate executives and those with a family history of heart attacks. “My life is dedicated to prevention and reversal of cardiovascular disease and giving hope to the thousands of people who suffer from this disease. Most patients who come to me have been told they require angioplasty stents or heart bypass surgery but want to avoid them as a matter of personal choice or for cultural or social reasons. Then there are patients are unfit for surgery or where these have failed. Sibia Medical Centre is the last hope for many of them” says Dr. Sibia.
Send Enquiry
Read More
Cardiac stents might have no benefit While India tries out price caps on cardiac stents, more evidence emerges on their overuse globallyFor decades, cardiac stents have been placed in patients who might have got no benefit from them.by Menaka RaoPublished Nov 04, 2017 · 04:00 pmSource: https://scroll.in/pulse/856663/while-india-tries-out-price-caps-on-cardiac-stents-more-evidence-emerges-on-their-overuse-globallyOn Wednesday, medical journal The Lancet published a study that has questioned the common cardiac procedure of inserting stents into blocked arteries of patients with chest pains as one of the symptoms of heart disease. A stent is a short wire-mesh tube that acts as a scaffold to keep a blocked artery of the heart open. The study shows that stents do not necessarily alleviate chest pains when patients exert themselves. The results of the study have stunned cardiologists, The New York Times reported, as it counters decades of clinical practice.The study brings back into focus the practice of irrational use of cardiac stents globally and in India.The study recruited 200 patients with severe artery blood vessel blockage, who experienced ischemic symptoms that arise when blood flow becomes impaired resulting in chest pain, fatigue, dizziness and palpitations. In such patients, doctors recommend angioplasty – a procedure in which a stent is inserted in the narrowed artery using a catheter. The study involved a control group that underwent a placebo procedure, where the catheter was inserted into the body but no stent was placed in the artery. After six weeks of medication to control heart disease as well as to ease chest pain, the patients who had stents placed and the control group both reported no significant difference in their ability to exercise.Blockage in a heart vessel may be treated in three ways – medication, stenting or bypass surgery.A 2012 study showed that bypass was a better treatment modality for patients with diabetes and multivessel blockage as compared to angioplasty.“We have known that a stable patient with stable angina and block need not undergo angioplasty for years now, ” said Dr Sundeep Mishra, a consulting cardiologist at All India Institute of Medical Sciences, Delhi. “For some reason, it still continues.”Stable angina refers to people with narrowed vessels in their heart but either with no symptoms, or those who feel chest pain or heaviness only during physical activity.Mishra was referring to a major trial conducted in the United States and Canada 10 years ago, which showed that patients with stable coronary heart disease who underwent angioplasties with medical therapy did not have lower risks of heart attack or death from heart disease as compared to patients who were on medical therapy alone.Angioplasties are, however, still considered essential for people with unstable angina, where a partial or total block to a blood vessel can cause a heart attack. In such cases, the patient suffers chest pain even while resting. The procedure is lifesaving during a heart attack.“Stents are a good solid method of treatment, ” said Dr Suresh Joshi, a cardiac surgeon from Jaslok Hospital in Mumbai. “But, the indiscriminate use is just increasing over the years.”Pharma pushThe use of stents to treat stable angina and chest pain may largely be due to pharmaceutical company promotions.For instance, Abbott Healthcare and other multinational pharmaceutical companies marketed a bioresorbable stent as the latest innovation that was superior to the drug-eluting stents commonly used. While regular stents have a metal scaffold, the scaffold in bioresorbable stents are made of material that dissolves in the blood vessel over a period of time. The supposed advantage of a bioresorbable stent is that the device is no longer needed after the blood vessel has healed and can be disposed of within the body.However, there was little clinical evidence to show that bioresorbable stents are superior to drug-eluting stents. After the US Food and Drug Administration and other regulatory agencies raised concerns that bioresorbable stents might actually increase risks of adverse cardiac events, Abbott decided to withdraw the product from several global markets, including India. The NPPA allowed the product to be withdrawn on safety grounds.Inappropriate useWhile there is no data to show that stents are being used irrationally in India, public health experts and doctors say that such overuse is indicated by the way in which cardiac treatment procedures are prescribed and the amount of money that patients spend on them.“The catastrophic spending on this procedure is linked to the business model which involves commissions to hospitals and kickbacks to doctors, ” said Malini Aisola of the All India Drug Action Network, a group of nonprofit organisations that works towards increasing access to medicines. “It would not be unreasonable to expect that there would be some level of irrational stenting.”In February this year, the National Pharmaceutical Pricing Authority or NPPA fixed a ceiling price for stents at approximately Rs 30, 000. Apart from increasing access and affordability of the devices, health activists expect that the price cap may also reduce irrational use of stents.India has no standard treatment guidelines on managing coronary heart disease or on the use of stents.In 2016, seven leading cardiologists in the country put together detailed guidelines for the management of stable coronary heart disease, that were published in the Indian Heart Journal. These were supposed to be a quick guide for those clinicians inundated with data who “may not have sufficient time to go through” it all. Mishra, who is one of the authors of the guidelines, said that stents should be used in case of profound blockages in some major arteries in the heart or a heart attack. In case of stable heart disease, the disease can be managed by medications, and only if it does not work do cardiologists have to resort to either use of stents or bypass.“We need standard treatment guidelines in the country, ” said Aisola. “We also need to have medical audits that can give us some idea about the extent of irrational use of stents.We welcome your comments at letters@scroll.in.TAgs: Cardiac Stent, Angioplasty, Chest Pain, Price Cap, The Lancet,
Send Enquiry
Read More
Page 1 0.9